>
So long, Paris: US officially leaves landmark climate pact – Trump has formally removed the U.S...
VIDEO: Ilhan Omar Caught In Massive Money Laundering Operation With Fake Winery!
HISTORIC BOMBSHELL: Trump Federalizes Large Parts Of California After A Year Long Federal...
Washington Post staffers beg owner Jeff Bezos to spare their jobs amid plans to slash HUNDREDS...
Researchers who discovered the master switch that prevents the human immune system...
The day of the tactical laser weapon arrives
'ELITE': The Palantir App ICE Uses to Find Neighborhoods to Raid
Solar Just Took a Huge Leap Forward!- CallSun 215 Anti Shade Panel
XAI Grok 4.20 and OpenAI GPT 5.2 Are Solving Significant Previously Unsolved Math Proofs
Watch: World's fastest drone hits 408 mph to reclaim speed record
Ukrainian robot soldier holds off Russian forces by itself in six-week battle
NASA announces strongest evidence yet for ancient life on Mars
Caltech has successfully demonstrated wireless energy transfer...
The TZLA Plasma Files: The Secret Health Sovereignty Tech That Uncle Trump And The CIA Tried To Bury

The Department of Health and Human Services report, which is expected to be published this month, will raise "low folate levels and acetaminophen during pregnancy" as possible causes of autism, people familiar with the matter told the Wall Street Journal.
The review will also highlight folinic acid, known as leucovorin, as a possible therapy to ease autism symptoms in some patients, sources told the Journal.
Autism affected about one in 31 8-year-olds in the US in 2022, according to federal estimates.
Tylenol, manufactured by McNeil Consumer Healthcare, a Kenvue subsidiary, is one of the most widely used over-the-counter painkillers — including among pregnant women.
Its active ingredient, acetaminophen, has been studied for decades.
Some research has suggested risks to fetal development, but other studies found no such link.
"We are using gold-standard science to get to the bottom of America's unprecedented rise in autism rates," an HHS spokesperson told The Post Friday.
"Until we release the final report, any claims about its contents are nothing more than speculation."
The Post has sought comment from Kenvue.
Shares of Kenvue plummeted by 16% after the Journal initially published its story during the course of trading on Wall Street on Friday afternoon — though the stock recovered somewhat near the closing bell.
The American College of Obstetricians and Gynecologists continues to say Tylenol is safe for pregnant women, though it advises all expectant mothers to consult doctors before taking any medication.
Kennedy's report will review existing scientific literature, not a new clinical study, sources told the Journal.
Researchers have long cautioned that pinpointing autism's causes takes years of rigorous work, with genetic factors already proven to play a major role.
"Nothing is more important to us than the health and safety of the people who use our products," a Kenvue spokeswoman told the WSJ.
"We have continuously evaluated the science and continue to believe there is no causal link between acetaminophen use during pregnancy and autism."
The looming report could go beyond Tylenol, sources told the Journal, by listing other possible causes of autism and calling for more research.
It is not yet clear whether vaccines — the longtime target of Kennedy's skepticism — will be included.